Monthly ultra-low-dose THC in an Alzheimer mouse model attenuated cognitive decline in both sexes, with males showing reduced hippocampal inflammation and females showing reduced prefrontal cortex inflammation.
Alzheimer researchers, neuroprotection scientists, cannabinoid pharmacologists
Preventive ULD-THC attenuated cognitive decline with sex-specific inflammation reduction
What the researchers found
ULD-THC attenuated AD-related cognitive decline in both sexes. Males showed reduced hippocampal inflammation; females showed reduced prefrontal cortex inflammation. Treatment was given monthly from 3 to 5 months of age, before significant pathology.
Why it matters
No treatment effectively prevents Alzheimer onset. Ultra-low-dose THC, given before symptoms, reduced neuroinflammation and slowed cognitive decline without the adverse effects of chronic THC use.
The numbers in context
Monthly ULD-THC from age 3-5 months. Testing at 6 months. Males: reduced hippocampal inflammation. Females: reduced PFC inflammation. Both sexes: attenuated cognitive decline.
How the study worked
Male and female 5xFAD mice received monthly ULD-THC injections from 3-5 months. Behavioral assessments at 6 months, followed by molecular analyses of hippocampal and PFC tissue.
What this study cannot tell us
Mouse model. Difficult to translate ULD-THC dosing to humans. Only tested as prevention, not treatment. Short treatment window.
How to read the evidence
Well-designed preclinical study with sex-stratified analysis, but mouse model results require extensive human validation.
When this study was published
2026 publication
The bigger picture
If doses too low to produce psychoactive effects can still provide neuroprotection, it could open a new therapeutic category with minimal side effect concerns.
Questions still open
- What is the human-equivalent dose? Would this work after pathology is established? Why do sexes show protection in different brain regions?
Common questions
Could THC prevent Alzheimer disease?
What makes this ultra-low-dose?
Read the original research
Sex-dependent effects of ultra-low-dose-THC preventive treatment on neuroinflammation and cognitive decline in 5xFAD mice.
Biology of sex differences, 17(1), 20
Citation
Nitzan, Keren; Bentulila, Ziv; Bregman-Yemini, Noa; Ayalon, Niv; David, Dekel; Break, Emanuela; Sarne, Yossi; Doron, Ravid. (2026). Sex-dependent effects of ultra-low-dose-THC preventive treatment on neuroinflammation and cognitive decline in 5xFAD mice.. Biology of sex differences, 17(1), 20. https://doi.org/10.1186/s13293-025-00815-3
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)